Yu SCH - Search Results

1

A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma.

Chan SL, Cheng PNM, Liu AM, Chan LL, Li L, Chu CM, Chong CCN, Lau YM, Yeo W, Ng KKC, Yu SCH, Mok TSK, Chan AWH. Chan SL, et al. Among authors: yu sch. Invest New Drugs. 2021 Oct;39(5):1375-1382. doi: 10.1007/s10637-021-01111-8. Epub 2021 Apr 15. Invest New Drugs. 2021. PMID: 33856599 Free PMC article. Clinical Trial.

2

False-negative rate of abdominal sonography for detecting hepatocellular carcinoma in patients with hepatitis B and elevated serum alpha-fetoprotein levels.

Mok TS, Yu SC, Lee C, Sung J, Leung N, Lai P, Leung TW, Chan AT, Yeo W, Koh J, Johnson P. Mok TS, et al. AJR Am J Roentgenol. 2004 Aug;183(2):453-8. doi: 10.2214/ajr.183.2.1830453. AJR Am J Roentgenol. 2004. PMID: 15269040

3

A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.

Yeo W, Mok TS, Zee B, Leung TW, Lai PB, Lau WY, Koh J, Mo FK, Yu SC, Chan AT, Hui P, Ma B, Lam KC, Ho WM, Wong HT, Tang A, Johnson PJ. Yeo W, et al. J Natl Cancer Inst. 2005 Oct 19;97(20):1532-8. doi: 10.1093/jnci/dji315. J Natl Cancer Inst. 2005. PMID: 16234567 Clinical Trial.

4

An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results.

Mok TS, Yeo W, Yu S, Lai P, Chan HL, Chan AT, Lau JW, Wong H, Leung N, Hui EP, Sung J, Koh J, Mo F, Zee B, Johnson PJ. Mok TS, et al. J Clin Oncol. 2005 Nov 1;23(31):8041-7. doi: 10.1200/JCO.2005.01.9927. J Clin Oncol. 2005. PMID: 16258102

5

Transarterial ethanol ablation of hepatocellular carcinoma with lipiodol ethanol mixture: phase II study.

Yu SC, Hui EP, Wong J, Wong H, Mo F, Ho SS, Wong YY, Yeo W, Lai PB, Chan AT, Mok TS. Yu SC, et al. J Vasc Interv Radiol. 2008 Jan;19(1):95-103. doi: 10.1016/j.jvir.2007.08.038. J Vasc Interv Radiol. 2008. PMID: 18192473 Clinical Trial.

6

Embolization efficacy and treatment effectiveness of transarterial therapy for unresectable hepatocellular carcinoma: a case-controlled comparison of transarterial ethanol ablation with lipiodol-ethanol mixture versus transcatheter arterial chemoembolization.

Yu SC, Hui JW, Hui EP, Mo F, Lee PS, Wong J, Lee KF, Lai PB, Yeo W. Yu SC, et al. J Vasc Interv Radiol. 2009 Mar;20(3):352-9. doi: 10.1016/j.jvir.2008.12.407. Epub 2009 Jan 23. J Vasc Interv Radiol. 2009. PMID: 19167240

7

Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group.

Yeo W, Chung HC, Chan SL, Wang LZ, Lim R, Picus J, Boyer M, Mo FK, Koh J, Rha SY, Hui EP, Jeung HC, Roh JK, Yu SC, To KF, Tao Q, Ma BB, Chan AW, Tong JH, Erlichman C, Chan AT, Goh BC. Yeo W, et al. J Clin Oncol. 2012 Sep 20;30(27):3361-7. doi: 10.1200/JCO.2011.41.2395. Epub 2012 Aug 20. J Clin Oncol. 2012. PMID: 22915658 Free PMC article. Clinical Trial.

8

Re: roles played by chemolipiodolization and embolization in chemoembolization for hepatocellular carcinoma: single-blind, randomized trial.

Chan SL, Hui EP, Yu S, Yeo W. Chan SL, et al. J Natl Cancer Inst. 2013 Apr 17;105(8):580. doi: 10.1093/jnci/djt047. Epub 2013 Mar 15. J Natl Cancer Inst. 2013. PMID: 23503599 No abstract available.

9

Performance of serum α-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass.

Chan SL, Mo F, Johnson PJ, Siu DY, Chan MH, Lau WY, Lai PB, Lam CW, Yeo W, Yu SC. Chan SL, et al. HPB (Oxford). 2014 Apr;16(4):366-72. doi: 10.1111/hpb.12146. Epub 2013 Aug 26. HPB (Oxford). 2014. PMID: 23980880 Free PMC article.

10

International validation of the Chinese university prognostic index for staging of hepatocellular carcinoma: a joint United Kingdom and Hong Kong study.

Chan SL, Johnson PJ, Mo F, Berhane S, Teng M, Chan AW, Poon MC, Lai PB, Yu S, Chan AT, Yeo W. Chan SL, et al. Chin J Cancer. 2014 Oct;33(10):481-91. doi: 10.5732/cjc.014.10133. Epub 2014 Sep 16. Chin J Cancer. 2014. PMID: 25223914 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

196 results

Search Page